Literature DB >> 6321142

Effect of dexamethasone on immunoreactive corticotropin-releasing factor in the rat median eminence and intermediate-posterior pituitary.

T Suda, N Tomori, F Tozawa, T Mouri, H Demura, K Shizume.   

Abstract

Immunoreactive ACTH (I-ACTH) concentrations in the anterior pituitary, intermediate-posterior pituitary (IP), and plasma and immunoreactive corticotropin-releasing factor (I-CRF) concentrations in the median eminence and IP were determined in rats receiving dexamethasone for various periods from 16 h to 10 days. Plasma I-ACTH concentrations were decreased 16 h after a single injection of dexamethasone. Anterior pituitary I-ACTH concentrations did not decrease until 4 days after the start of dexamethasone medication. IP I-ACTH concentrations did not change throughout these periods. I-CRF concentrations in median eminence and IP rapidly decreased after dexamethasone administration. These results raise the possibility that the source of I-CRF in the IP is hypothalamic.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6321142     DOI: 10.1210/endo-114-3-851

Source DB:  PubMed          Journal:  Endocrinology        ISSN: 0013-7227            Impact factor:   4.736


  5 in total

1.  Corticotropin-releasing hormone links pituitary adrenocorticotropin gene expression and release during adrenal insufficiency.

Authors:  L J Muglia; L Jacobson; C Luedke; S K Vogt; M L Schaefer; P Dikkes; S Fukuda; Y Sakai; T Suda; J A Majzoub
Journal:  J Clin Invest       Date:  2000-05       Impact factor: 14.808

2.  Multiple feedback regulatory loops upon rat hypothalamic corticotropin-releasing hormone secretion. Potential clinical implications.

Authors:  A E Calogero; W T Gallucci; P W Gold; G P Chrousos
Journal:  J Clin Invest       Date:  1988-09       Impact factor: 14.808

3.  Strain-specific steroidal control of pituitary function.

Authors:  Sang-Nam Lee; Bonnie Peng; Roxane Desjardins; John E Pintar; Robert Day; Iris Lindberg
Journal:  J Endocrinol       Date:  2007-03       Impact factor: 4.286

4.  Hypothalamic and suprahypothalamic effects of prolonged treatment with dexamethasone in the rat.

Authors:  A E Calogero; C Liapi; G P Chrousos
Journal:  J Endocrinol Invest       Date:  1991-04       Impact factor: 4.256

5.  Immunoreactive corticotropin-releasing factor in human plasma.

Authors:  T Suda; N Tomori; F Yajima; T Sumitomo; Y Nakagami; T Ushiyama; H Demura; K Shizume
Journal:  J Clin Invest       Date:  1985-11       Impact factor: 14.808

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.